Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

November 1, 2019

Conditions
Coronary Occlusion
Interventions
DEVICE

NovaCross™ Chronic Total Occlusion micro-catheter

The NovaCross™ micro catheter is a guidewire positioning and support micro catheter for improving chronic total occlusion (CTO) crossability. The NovaCross™ gains its supportive characteristics through the use of a unique operator-controlled Nitinol scaffold and an extendable segment. Investigators will use the NovaCross Micro catheter during a standard of care catheterization of patients diagnosed with coronary total occlusion.

Trial Locations (3)

Unknown

Rabin Medical Center, Petah Tikva

Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie, Krakow

Belfast City Hospital, Belfast

All Listed Sponsors
lead

Nitiloop Ltd.

INDUSTRY

NCT03717675 - Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter | Biotech Hunter | Biotech Hunter